Presentations & Publications

Presentation

Phase 1/2 study of ADXS31-142 alone and in combination with pembrolizumab in patients with previously treated metastatic castration-resistant prostate cancer (mCRPC): The KEYNOTE-046 trial

SITC, November 5, 2015

Publication

Immunotherapy of Breast Cancer: World Congress on Breast Cancer

August 2015

Presentation

Combination Lm-LLO Immunotherapy plus Radiation Delays Tumor Progression and Prolongs Survival in Osteosarcoma

ACVIM, June 8, 2015

Publication

Anti-Tumor Therapeutic Effects in Mice Treated With Listeria Monocytogenes (Lm)-LLO Immunotherapy In Combination with anti–PD-L1

AACR, April 21, 2015

Presentation

AACR 2015 Reception Presentation with Late Breaking Poster

AACR, April 19, 2015

Publication

Listeria vaccines join the checkpoint frenzy.

Published in Nat Biotechnol, December 2014

Publication

Lm-LLO Immunotherapies Targeting Multiple Antigens and Their Impact on Different Mechanisms in the Tumor Microenvironment

SITC, November 10, 2014

Presentation

A recombinant HER2/Neu expressing Listeria monocytogenes (Lm9LLO) immunotherapy delays metastatic disease and prolongs overall survival in a spontaneous canine model of osteosarcoma

SITC, November 10, 2014

Publication

Episomal expression of truncated listeriolysin O in LmddA-LLO-E7 vaccine enhances antitumor efficacy by preferentially inducing expansions of CD4+ FoxP3- and CD8+ T cells

Published in Cancer Immunology Research, May 28, 2014

Publication

Listeria monocytogenes (Lm)-LLO Immunotherapies Reduce the Immunosuppressive Activity of Myeloid-derived Suppressor Cells and Regulatory T Cells in the Tumor Microenvironment

Published in the Journal of Immunotherapy, November 2013

Publication

ADXS11-001 LM-LLO Immunotherapy Targeting HPV-E7: Preliminary Safety and Survival Data From a Phase 2 Study in Indian Women With Recurrent/Refractory Cervical Cancer

Published in the Journal for Immunotherapy of Cancer, November 2013

Publication

Anti-PD-1 antibody significantly increases therapeutic efficacy of Listeria monocytogenes (Lm)-LLO immunotherapy

Published in the Journal for ImmunoTherapy of Cancer, August 29, 2013

Publication

Listeria monocytogenes-Derived Listeriolysin O Has Pathogen Associated Molecular Pattern-Like Properties Independent of Its Hemolytic Ability

Published in Clinical and Vaccine Immunology, January 2013

Publication

Combined immunotherapy with Listeria monocytogenes-based PSA vaccine and radiation therapy leads to a therapeutic response in a murine model of prostate cancer.

Published in Cancer Immunology Immunotherapy, December 2012

Publication

Immune Response and Immunotherapy: Live Attenuated Listeria monocytogenes (Lm)-LLO Immunotherapy for the Treatment of Prostate Cancer

Published in Current Cancer Therapy Reviews, November 1, 2012